what is a glp 1 antagonist The Premise of the Paradox: Examining the Evidence That Motivated GIPR Agonist and Drug Development Programs Frontiers | GLP-1 Receptor Agonists:

The ingredient-level research on this specific stack is substantive and covered in full below

50 In vitro experiments suggest that SEMA may participate in regulating the fibrosis process by improving factors such as inflammatory or metabolic triggers of fibrosis, like IL-6 and free fatty acids, as well as fibrotic structural features

Removing the lesion is a common solution

The original patent documentation describes this mechanism in detail, noting that the peptide stimulates lipolysis and inhibits lipogenesis via beta-adrenergic signalling at concentrations far below those needed to activate growth-promoting pathways